John E. Godwin, MD  

John E. Godwin, MD
Division of Hematology/Oncology
Professor of Medicine
Chief, Division of Hematology/Oncology
Associate Director of Clinical Programs, SimmonsCooper Cancer Institute

Office Location: 415 North 9th Street
Carol Jo Vecchie, Room 2W106
Springfield, Illinois 62702
Appointments: 217-545-5817


Degree Year Institution Area
BS 1974 University of Montevallo Science
MD 1978 University of Alabama School of Medicine Medicine
MS 1983 University of Texas School of Public Health Epidemiology
Residency 1978 Baylor College of Medicine Medicine
Fellowship 1981 Baylor College of Medicine Internal Medicine
Fellowship 1982 Baylor College of Medicine Hematology/Oncology
Fellowship/Research 1983 University of North Carolina
National Research Service Award		 Hematology/Oncology
 
Board Certifications
National Boards in Medicine, National Board of Medical Examiners
Internal Medicine, American Board of Internal Medicine
Hematology Subspecialty Board, American Board of Internal Medicine
 
Academic Interests

Dr. Godwin is a national principal investigator in clinical trials in acute myeloid leukemia and chronic lymphocytic leukemia. He is a principal investigator in several clinical trials sponsored at SIU and CICCOP.

Dr. Godwin is also working with development of cancer care delivery and support models in our team approach to cancer care. He is involved with national research on Cancer Control including Symptom Control and Quality of Life, Cancer Survivors, health disparities, and Molecular Epidemiology of Cancer.

 
Clinical Interests

Specializes in acute and chronic leukemias, lymphoma, myeloproliferative diseases, myelodysplastic syndrome (MDS), bleeding and clotting disorders, head and neck, and Lung cancer. Dr. Godwin sees patients with our multidisciplinary Head and Neck, and Lung, and Breast cancer care teams, as well as in our adult Hematology/Oncology clinic. He specializes in Phase II and III clinical trials in cancer.
 
Representative Publications
  1. Godwin, J. E., Kopecky, KJ, Head, DR, Willman, CL, Leith, CP, Hynes, HE , Balcerzak, SP, Appelbaum, FR. (1998) A double blind placebo controlled trial of G-CSF in elderly patients with previously untreated acute myeloid leukemia. A Southwest Oncology Group Study (9031). Blood 91:3607-3615.
  2. Weiss, J.R., Kopecky, K.J., Godwin, J., Anderson, J., Willman, C.L., Moysich, K.B., Slovak, M.L., Hoque, A., Ambrosone, C.B. (2006) Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for AML: Pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials. Leukemia 20(12):2169-2171; Sep 28; [Epub ahead of print].
  3. Kuptsova, N., Kopecky, K.J., Godwin, J., Anderson, J., Hoque, A., Willman, C.L., Slovak, M.L., Ambrosone, C.B. (2007) Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 109(9):3936-44; Dec 29; [Epub ahead of print].
  4. Patel, P., Godwin, J., Velankar, M., Alkan, S. (2007) Nodal ALK positive anaplastic large cell lymphoma of the axilla with spontaneous regression. Letter to the Editor. Leuk Lymphoma 48(6):1250-1252.
  5. Godwin, J., Kolluri, R. (2007) Surgical hemostasis and clotting mechanisms. In: Essential Otolaryngology, 9th ed., K. J. Lee (ed), McGraw-Hill, New York, in press.

BulletTop